Fetal growth restriction (FGR)is a complex disorder of human pregnancy that leads to poor health outcomes in offspring. These range from immediate risks such as perinatal morbidity and stillbirths, to long-term complications including severe neurodevelopmental problems. Despite its relatively high global prevalence, the aetiology of FGR and its complications is not currently well understood. We now know that serotonin (5-HT)is synthesised in the placenta and is crucial for early fetal forebrain development in mice. However, the contribution of a disrupted placental 5-HT synthetic pathway to the pathophysiology of placental insufficiency in FGR and its significant fetal neurodevelopmental complications are unclear.
CITATION STYLE
Ranzil, S., Walker, D. W., Borg, A. J., Wallace, E. M., Ebeling, P. R., & Murthi, P. (2019, June 1). The relationship between the placental serotonin pathway and fetal growth restriction. Biochimie. Elsevier B.V. https://doi.org/10.1016/j.biochi.2018.12.016
Mendeley helps you to discover research relevant for your work.